What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Asthma
His primary areas of investigation include Asthma, Pediatrics, Immunology, Allergy and Atopic dermatitis.
His research in Asthma is mostly concerned with Wheeze.
The concepts of his Pediatrics study are interwoven with issues in Prevalence, Epidemiology, Retrospective cohort study, Family medicine and Risk factor.
His studies deal with areas such as Bronchial hyperresponsiveness and Genotype as well as Immunology.
Soo-Jong Hong has included themes like Clinical study design, Bronchoconstriction and Airway hyperresponsiveness in his Allergy study.
His study in Atopic dermatitis is interdisciplinary in nature, drawing from both Staphylococcal Skin Infections, Methicillin-resistant Staphylococcus aureus, Ciprofloxacin, Systemic immunity and Dysbiosis.
His most cited work include:
- International consensus on (ICON) pediatric asthma (258 citations)
- Xenon Ventilation CT with a Dual-Energy Technique of Dual-Source CT: Initial Experience (135 citations)
- The prevalences of asthma and allergic diseases in Korean children (123 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Asthma, Immunology, Atopic dermatitis, Pediatrics and Allergy.
His study looks at the relationship between Asthma and fields such as Odds ratio, as well as how they intersect with chemical problems.
His research brings together the fields of Genotype and Immunology.
His studies in Atopic dermatitis integrate themes in fields like Offspring, Gut flora and Physiology.
His Pediatrics research is multidisciplinary, relying on both Wheeze, Epidemiology and Risk factor.
Allergy is closely attributed to Disease in his research.
He most often published in these fields:
- Asthma (36.89%)
- Immunology (38.33%)
- Atopic dermatitis (21.61%)
What were the highlights of his more recent work (between 2018-2021)?
- Immunology (38.33%)
- Asthma (36.89%)
- Atopic dermatitis (21.61%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Asthma, Atopic dermatitis, Sensitization and Physiology.
His Bronchial hyperresponsiveness research extends to Immunology, which is thematically connected.
His Asthma study combines topics in areas such as Allergy, Methacholine, Odds ratio and Cohort.
As part of the same scientific family, he usually focuses on Methacholine, concentrating on Spirometry and intersecting with Inhalation exposure, Diffusing capacity and Pediatrics.
His Atopic dermatitis study incorporates themes from Offspring, Immunoglobulin E, Gut flora and Interleukin 13.
He interconnects Dermatology and House dust mite in the investigation of issues within Sensitization.
Between 2018 and 2021, his most popular works were:
- Different upper airway microbiome and their functional genes associated with asthma in young adults and elderly individuals. (15 citations)
- Antibiotics-Induced Dysbiosis of Intestinal Microbiota Aggravates Atopic Dermatitis in Mice by Altered Short-Chain Fatty Acids (13 citations)
- Antibiotics-Induced Dysbiosis of Intestinal Microbiota Aggravates Atopic Dermatitis in Mice by Altered Short-Chain Fatty Acids (13 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Asthma
Asthma, Immunology, Atopic dermatitis, Pregnancy and Interleukin are his primary areas of study.
Asthma is a subfield of Internal medicine that he investigates.
The Immunology study combines topics in areas such as Disease cluster and Disease.
His Atopic dermatitis research integrates issues from Atopy, Phenotype, Cohort study and Cord blood.
His Pregnancy research includes themes of New diagnosis and Respiratory tract infections.
Soo-Jong Hong interconnects Immunoglobulin E, Gut flora, Innate lymphoid cell and Sensitization in the investigation of issues within Interleukin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
